FDA: Page 2
-
Deep Dive
4 medtech topics to watch for the rest of 2025
From M&A to MDUFA and the developing market in renal denervation, MedTech Dive covers the key issues to watch in the final months of the year.
By Ricky Zipp , Susan Kelly , Elise Reuter • Aug. 25, 2025 -
Boston Scientific recalls carotid stents over manufacturing defect
The FDA said the defect could injure blood vessels, damage the stent or release debris that could travel to the brain and cause a stroke.
By Nick Paul Taylor • Aug. 25, 2025 -
Explore the Trendline➔
Permission granted by Boston ScientificTrendlineNew medical devices are reshaping the medtech industry
From pulsed field ablation devices to glucose sensors and surgical robotics, new medical technologies are transforming patient care and how people manage their health.
By MedTech Dive staff -
More than 1,100 devices have received the FDA’s breakthrough designation
The FDA updated its list of breakthrough devices as medtech groups lobby for faster Medicare coverage of products with the designation.
By Elise Reuter • Aug. 21, 2025 -
Q&A
How Aktiia built the first over-the-counter cuffless blood pressure monitor
Aktiia received FDA clearance in July for the first cuffless blood pressure monitor authorized to be sold over the counter.
By Elise Reuter • Aug. 20, 2025 -
NeuroOne gains FDA clearance for trigeminal nerve ablation
The minimally invasive system uses radiofrequency energy to target nerve tissue causing facial pain.
By Susan Kelly • Aug. 20, 2025 -
Medtronic recall of heart vent catheters tied to 3 serious injuries
The FDA said the request to quarantine the devices followed reports of the products “resisting shape retention when being bent.”
By Nick Paul Taylor • Aug. 19, 2025 -
Boston Scientific updates instructions of devices linked to 17 deaths
The update covers devices used in procedures to implant the company’s Watchman heart device.
By Nick Paul Taylor • Aug. 8, 2025 -
Boston Scientific tells users about defibrillator problem linked to deaths, injuries
A company spokesperson said in a statement to MedTech Dive that direct causation between the deaths and calcification of the leads cannot be assumed or confirmed.
By Nick Paul Taylor • Aug. 7, 2025 -
Medical device industry says future MDUFA hikes unsustainable
Device lobbyists’ priorities contrasted with patient advocates, who sought an increase in user fees and more funds for postmarket safety.
By Elise Reuter • Aug. 5, 2025 -
News roundup
Monogram robot marks autonomy milestone; Stereotaxis catheter cleared
Monogram Technologies conducted its first fully autonomous robotic knee replacement surgery, while Stereotaxis won FDA clearance for a robotically navigated electrophysiology mapping catheter.
By Susan Kelly • July 31, 2025 -
Cardiosense wins FDA clearance for wearable heart monitor
The device captures various types of heart data that could be used in AI models for cardiovascular parameters with the aim of lowering barriers to monitoring.
By Nick Paul Taylor • July 31, 2025 -
Edwards recalls arterial cannulas over exposed wires
Exposed wires could puncture the artery and cause bleeding, inadequate perfusion and hemolysis, the FDA said in its Class I recall notice.
By Nick Paul Taylor • July 25, 2025 -
Baxter recalls certain Novum pumps over issues tied to 79 injuries, 2 deaths
The company has advised users to change the pump and infusion set at a time when a delay in treatment would not harm the patient.
By Nick Paul Taylor • July 23, 2025 -
Whoop’s FDA warning letter sparks debate over blood pressure as a wellness metric
Whoop pushed back on the warning letter, claiming its blood pressure feature for a wearable wristband is for “wellness” and should not be regulated as a medical device.
By Elise Reuter • July 18, 2025 -
Integra recalls cranial drills over defect linked to 10 injuries
The defect has resulted in problems including a procedural delay, difficulty removing device fragments and bleeding, the FDA said.
By Nick Paul Taylor • July 17, 2025 -
Boston Scientific gets expanded PFA label for persistent AFib
Patients whose atrial fibrillation lasts longer than seven days and who do not respond well to drug therapy are now eligible for treatment with the Farapulse pulsed field ablation system.
By Susan Kelly • July 8, 2025 -
J&J’s Abiomed recalls heart pump controllers after 3 patients die
The FDA published an early alert, which the agency reserves for potentially high-risk issues.
By Nick Paul Taylor • Updated July 8, 2025 -
Olympus pledges prompt response following FDA import block
Endoscopy devices restricted from import accounted for about 1% of the company’s consolidated revenue in its latest fiscal year, Olympus said.
By Susan Kelly • June 30, 2025 -
Cook Medical recalls catheters over fault linked to 3 serious injuries
The company began the recall after receiving four field complaints about tip separation before and during use.
By Nick Paul Taylor • June 27, 2025 -
Medtronic recall of capsule delivery devices tied to 33 serious injuries
The Food and Drug Administration published an early alert for the recall on Tuesday. No deaths have been associated with the problem.
By Ricky Zipp • June 25, 2025 -
FDA stops Olympus devices from entering the US
The agency said it issued the import alerts because it “continues to have concerns related to outstanding Quality System regulation violations by Olympus.”
By Nick Paul Taylor • June 25, 2025 -
GE Healthcare recalls Carestation devices over ventilation failure risk
The recall affects 15 Carestation models and more than 14,000 individual devices.
By Nick Paul Taylor • June 24, 2025 -
Q’Apel recalls clot removal device in response to FDA warning letter
Rather than pursuing a new regulatory pathway, Q'Apel said it is discontinuing the recalled system “as part of its strategic shift toward newer technologies.”
By Nick Paul Taylor • June 18, 2025 -
Zyno recalls infusion pumps over unvalidated software
Customers have been asked to stop using the pumps and wait for someone to contact them about exchanging devices.
By Nick Paul Taylor • June 17, 2025 -
Could the FDA take an indirect approach to regulate LDTs?
Attorneys said many questions remain about LDT regulation after the FDA lost its legal fight. A recent warning letter could be a clue to future enforcement.
By Susan Kelly • June 16, 2025